Jefferies maintained a buy rating on Sun Pharma with a target price of Rs 1310. The Q2 miss was largely on higher operating expenses.
Red October: FPI stock selloff at Rs 81,000 crore, highest in a month
The selloff in October is in contrast to their activity in the rest of 2024. So far this month, foreigners have sold stocks worth ₹6,100